Zealand Pharma A/S (NASDAQ:ZEAL)

25.44
Delayed Data
As of 1:17pm ET
 +0.60 / +2.42%
Today’s Change
11.51
Today|||52-Week Range
25.50
+119.13%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Zealand Pharma A/S have a median target of 28.27, with a high estimate of 34.80 and a low estimate of 24.87. The median estimate represents a +11.12% increase from the last price of 25.44.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Zealand Pharma A/S. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.41
Sales
$1.5M
Reporting Date
Nov 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 36.34%
 
 
 
 
 
 
Growthannually -169.50%
 
 
 
 
 
 

Sales

Growthquarterly -49.60%
 
 
 
 
 
 
Growthannually 268.41%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.